Legato Capital Management LLC
Position in TBPH — Theravance Biopharma, Inc.
CIK 1442641
San Francisco, CA
Position in TBPH
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$521,583
+$32,186 QoQ
Shares Held
32,137
+22.9% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legato Capital Management LLC holds $63,394,532 across 48 Biotechnology names. TBPH ranks #31 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
39,554 | $6,467,870 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,004 | $4,638,930 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
22,378 | $4,467,767 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
56,326 | $4,182,768 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
41,763 | $3,858,065 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
37,394 | $3,636,566 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
15,538 | $2,626,232 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
29,968 | $2,522,406 |
All Filings in TBPH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $521,583 | 32,137 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $489,397 | 26,157 | Shares | Other | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||